Veterinary Medicines

Virbagen canis B Suspension for injection for dogs

Authorised
  • Borreliella afzelii, Inactivated
  • Borreliella garinii, Inactivated
Download as PDF

Product identification

Medicine name:
Virbagen canis B Suspension for injection for dogs
Virbagen canis B Injektionssuspension für Hunde
Active substance:
  • Borreliella afzelii, Inactivated
  • Borreliella garinii, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Borreliella afzelii, Inactivated
    1.00
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Borreliella garinii, Inactivated
    1.00
    relative unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID4) 20 millilitre(s): Box (Cardboard) with 20 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)
  • (ID5) 50 millilitre(s): Box (Cardboard) with 50 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)
  • (ID1) 2 millilitre(s): Box (Cardboard) with 2 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)
  • (ID2) 5 millilitre(s): Box (Cardboard) with 5 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)
  • (ID6) 100 millilitre(s): Box (Cardboard) with 100 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)
  • (ID3) 10 millilitre(s): Box (Cardboard) with 10 Vial (Glass type I) each with 1 millilitre(s), closed with Stopfen and Kappe (Gummi, Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11433.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0250/001
Concerned member states:
  • Austria

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/08/2025
Download